“…8 Regardless of the underlying mechanisms, elevated pulmonary artery pressure (PAP), pulmonary vascular resistance, and RVD appear to be important clinical markers in patients with CHF: they predict reduced survival and response to therapies, as well as poor outcome after orthotopic heart transplantation. [9][10][11] Patients responding to CHF therapy, including pharmacological, electrical, and mechanical, usually show improvements in PH and RVD (as a consequence of decreased left ventricular diastolic pressures). 8 Subjects developing RVD in the context of left heart disease commonly necessitate high doses of loop diuretics in order to relieve right-sided congestion, possibly because of lower cardiac output and high renal venous pressures with reduced glomerular filtration rate.…”